Summer Sale

50% off Premium Yearly

00days
00hrs
00mins
00secs

Medwell Capital Corp. (MWC.V)

RISKY
Very interesting biotechnology targeted to MS. Ranks well in his model at 15 because of the strong performance of the stock. Early-stage company.
COMMENT
In phase 3 pivotal trial for secondary progressive MS and about a year away from getting data. Just got FDA approval to start trials in the US. Very high Risk and very high Reward.
Showing 1 to 2 of 2 entries
  • «
  • 1
  • »

Medwell Capital Corp. (MWC.V) Frequently Asked Questions

What is Medwell Capital Corp. stock symbol?

Medwell Capital Corp. is a OTC stock, trading under the symbol MWC.V (previously MWC-X on Stockchase) on the undefined (undefined). It is usually referred to as or MWC.V

Is Medwell Capital Corp. a buy or a sell?

In the last year, no analyst issued a Buy, Sell, or Hold rating on MWC.V (previously MWC-X on Stockchase) on Stockchase. Read the latest expert commentary for Medwell Capital Corp..

Is Medwell Capital Corp. a good investment or a top pick?

Medwell Capital Corp. was never recommended as a Top Pick on Stockchase. Read the latest stock experts ratings for Medwell Capital Corp..

Why is Medwell Capital Corp. stock dropping?

Earnings reports or recent company news can cause the stock price to drop. Read stock experts' recommendations for Medwell Capital Corp..

Is Medwell Capital Corp. worth watching?

Medwell Capital Corp. is covered by Stockchase experts and is worth watching.